Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
This study investigated tigecycline exposure in critically ill patients from a population pharmacokinetic perspective to support rational dosing in intensive care unit (ICU) patients with acute and chronic liver impairment. A clinical dataset of 39 patients served as the basis for the development of...
Saved in:
Main Authors: | Lisa F. Amann (Author), Rawan Alraish (Author), Astrid Broeker (Author), Magnus Kaffarnik (Author), Sebastian G. Wicha (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetics of tigecycline in critically ill patients
by: Xiangru Luo, et al.
Published: (2023) -
Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling
by: Wei Su, et al.
Published: (2024) -
Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
by: Ibrahim MM, et al.
Published: (2018) -
Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
by: Song S, et al.
Published: (2024) -
Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing
by: Dzenefa Alihodzic, et al.
Published: (2020)